GLYECO, INC. (OTCMKTS:GLYE) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02

On December 5, 2016, Grant Sahag resigned as Chief Executive
Officer and Director of the GlyEco, Inc., a Nevada Corporation
(the Company). The resignation was not due to any disagreement
with the Company on any matter relating to its operations,
policies or practices.

On December 5, 2016, simultaneous with Mr. Sahags resignation,
the Company appointed Ian Rhodes, currently Chief Financial
Officer of the Company, as Chief Executive Officer. The Company
is currently in the process of finalizing an employment agreement
with Mr. Rhodes.

Ian Rhodes, 43, previously served as the Chief
Financial Officer of Calmare Therapeutics Incorporated,
abiotherapeutic company furthering proprietary and patented pain
mitigation and wound care technologies, from 2014 to 2016. As
Chief Financial Officer, Mr. Rhodes was responsible for all
financial and accounting matters, including SEC reporting. From
2012 to 2014, Mr. Rhodes served as an independent consultant and
entrepreneur, and his activities included leading an investor /
management group in assessing a potential multi-location
franchised food concept. From 2009 to 2012, he served as the Vice
President, Chief Accounting Officer, and Treasurer of Arch
Capital, where he had overall responsibility for SEC and GAAP
technical matters. Finally, from 1994 to 2009, Mr. Rhodes was
with PricewaterhouseCoopers LLP, where he served as Audit Senior
Manager from 2004 to 2009, during which time he worked with some
of the firms largest and most technically challenging audit
clients.

Family Relationships

There are no family relationships between any of the Companys
directors or officers and Mr. Rhodes.

Related Party Transactions

There are no related party transactions reportable under item
5.02 of Form 8-K and Item 404(a) of Regulation S-K.

On December 2, 2016, the Company held its 2016 Annual Meeting of
Stockholders (the Annual Meeting) at the offices of Robinson Brog
Leinwand Greene Genovese Gluck P.C. in New York, New York. As
described in the Companys Proxy Statement on Schedule 14A filed
with the U.S. Securities and Exchange Commission on October 19,
2016, at the Annual Meeting the Stockholders were asked to vote
on four matters: (i) electing seven (7) directors; (ii) ratifying
the appointment of KMJ Corbin Company, LLP as the Companys
independent registered certified public accountant for the fiscal
year ended December 31, 2016; (iii) approving, on an advisory
basis, the compensation of the Companys named executive officers;
and (iv) voting, on an advisory basis, on the preferred frequency
for which shareholders will have an advisory vote on the Companys
executive compensation.

At the Annual Meeting, stockholders representing 88,983,362
shares, or 74.41%, of the 119,575,964 shares of common
stockoutstanding on the record date of October 4, 2016, were
present in person or by proxy, constituting a quorum for the
purposes of theAnnual Meeting.

Proxies for the Annual Meeting were solicited to Section 14(a) of
the Securities Exchange Act of 1934, as amended, and there was no
solicitation in opposition to managements nominees for directors.
All nominees for director listed below were elected. The term of
office of each director will be until the 2017 Annual Meeting of
Stockholders and until their successors are elected and qualified
or until their earlier resignation or removal.

The voting results for the matters submitted to a vote of our
stockholders at the Annual Meeting are as follows:

Proposal No.1The election of 7 Directors to serve one-year
terms:

Proposal No.2Ratification of the appointment of KMJ Corbin
Company, LLP as the Companys independent registered public
accounting firm for the fiscal year ending December 31, 2016:

Proposal No.3Advisory approval of the compensation of the
Companys named executive officers:

Proposal No.4. Advisory vote on the preferred frequency
for which shareholders will have an advisory vote on the Companys
executive compensation:

Item 8.01 Other Events

On December 7, 2016, the Company issued a press release (the
Press Release) announcing the appointment of Mr. Rhodes as the
Companys new Chief Executive Officer and the resignation of Mr.
Sahag as the Chief Executive Officer and a Director of the
Company. A copy of the Press Release is attached hereto as
exhibit 99.1 to this Current Report on Form 8-K and is
incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

About GLYECO, INC. (OTCMKTS:GLYE)

GlyEco, Inc. is engaged in processing of waste glycol into recycled glycol products, specifically automotive antifreeze, and related specialty blended antifreeze, which it sells in the automotive and industrial end markets. The Company’s product offerings include High-Quality Recycled Glycols, Recycled Antifreeze, Recycled HVAC Fluids, Waste Glycol Disposal Services and Windshield Washer Fluid. The Company’s technology allows it to produce glycols, which can be used in industrial application. It formulates various universal recycled antifreeze products for engine coolants. In addition, it customs blend recycled antifreeze to customer specifications. It formulates a universal recycled, heating, ventilating and air conditioning (HVAC) coolant for HVAC fluids. Utilizing its fleet of collection/delivery trucks, the Company collects waste glycol from generators for recycling. It delivers Windshield Washer Fluid product into same store and new store customers as a non-recycled product.

GLYECO, INC. (OTCMKTS:GLYE) Recent Trading Information

GLYECO, INC. (OTCMKTS:GLYE) closed its last trading session 00.0000 at 0.0800 with 97,264 shares trading hands.